Rockefeller Financial Services Inc. boosted its position in shares of Chemed Corp. (NYSE:CHE) by 6.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,192 shares of the company’s stock after purchasing an additional 4,844 shares during the period. Rockefeller Financial Services Inc. owned approximately 0.54% of Chemed Corp. worth $17,415,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Kalos Management Inc. grew its holdings in Chemed Corp. by 0.7% during the 2nd quarter. Kalos Management Inc. now owns 6,521 shares of the company’s stock valued at $1,333,000 after purchasing an additional 45 shares in the last quarter. Capstone Asset Management Co. grew its holdings in Chemed Corp. by 2.7% during the 2nd quarter. Capstone Asset Management Co. now owns 1,857 shares of the company’s stock valued at $380,000 after purchasing an additional 49 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in Chemed Corp. by 0.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 11,600 shares of the company’s stock valued at $2,373,000 after purchasing an additional 50 shares in the last quarter. Amalgamated Bank grew its holdings in Chemed Corp. by 2.9% during the 2nd quarter. Amalgamated Bank now owns 2,203 shares of the company’s stock valued at $451,000 after purchasing an additional 62 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System grew its holdings in Chemed Corp. by 0.7% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 8,681 shares of the company’s stock valued at $1,776,000 after purchasing an additional 64 shares in the last quarter. 96.97% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts recently weighed in on CHE shares. Zacks Investment Research raised shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $216.00 price target for the company in a report on Monday, September 18th. TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $209.00 price target on shares of Chemed Corp. in a report on Friday, September 1st. Finally, BidaskClub lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $215.00.

Chemed Corp. (CHE) traded down 0.39% on Monday, reaching $209.37. 25,093 shares of the company’s stock were exchanged. The stock has a market capitalization of $3.35 billion, a PE ratio of 51.94 and a beta of 1.13. Chemed Corp. has a 12 month low of $132.92 and a 12 month high of $216.01. The firm has a 50 day moving average of $198.36 and a 200 day moving average of $198.61.

Chemed Corp. (NYSE:CHE) last announced its earnings results on Tuesday, July 25th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.26. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The business had revenue of $415.06 million for the quarter, compared to analyst estimates of $407.56 million. During the same quarter in the previous year, the firm posted $1.80 earnings per share. Chemed Corp.’s revenue was up 6.3% compared to the same quarter last year. Equities analysts predict that Chemed Corp. will post $8.21 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Chemed Corp. (CHE) Position Raised by Rockefeller Financial Services Inc.” was first published by Watch List News and is owned by of Watch List News. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/chemed-corp-che-position-raised-by-rockefeller-financial-services-inc/1649656.html.

In related news, insider Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $197.46, for a total transaction of $197,460.00. Following the transaction, the insider now owns 37,809 shares of the company’s stock, valued at $7,465,765.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Patrick P. Grace sold 500 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $201.48, for a total transaction of $100,740.00. Following the transaction, the director now directly owns 4,515 shares in the company, valued at approximately $909,682.20. The disclosure for this sale can be found here. Insiders have sold 16,500 shares of company stock worth $3,315,600 in the last ninety days. 4.90% of the stock is currently owned by insiders.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.